RAYMOND JAMES & ASSOCIATES - MEDICENNA THERAPEUTICS CORP ownership

MEDICENNA THERAPEUTICS CORP's ticker is MDNA and the CUSIP is 58490H107. A total of 26 filers reported holding MEDICENNA THERAPEUTICS CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of MEDICENNA THERAPEUTICS CORP
ValueSharesWeighting
Q3 2023$3,067
-38.8%
10,4000.0%0.00%
Q2 2023$5,010
-23.5%
10,4000.0%0.00%
Q1 2023$6,54810,4000.00%
Other shareholders
MEDICENNA THERAPEUTICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 350,000$1,054,0000.54%
AIGH Capital Management LLC 915,000$2,768,0000.50%
AWM Investment Company, Inc. 1,000,000$3,017,0000.30%
Board of Trustees of The Leland Stanford Junior University 962,932$2,898,0000.27%
Worth Venture Partners, LLC 215,030$647,0000.24%
SILVERARC CAPITAL MANAGEMENT, LLC 110,515$333,0000.15%
INTACT INVESTMENT MANAGEMENT INC. 385,600$1,427,0000.04%
Verition Fund Management LLC 539,051$1,623,0000.02%
Patriot Financial Group Insurance Agency, LLC 22,900$69,0000.01%
Maven Securities LTD 79,118$234,0000.01%
View complete list of MEDICENNA THERAPEUTICS CORP shareholders